An official website of the United States government
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Guideline Alliance (UK). Non-Hodgkin's Lymphoma: Diagnosis and Management. London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Activated B-cell
Angioimmunoblastic T-cell lymphoma
Non-anaplastic large cell lymphoma
Autologous stem cell transplantation
B-cell lymphoma 2
Burkitt's lymphoma
British National Formulary
Cancer antigen
Cost effectiveness acceptability curve
Cyclophosphamide, doxorubicin, vincristine and prednisolone
Cyclophosphamide, doxorubicin, etoposide, prednisolone and interferon-α
Central nervous system
Computed Tomogrpahy
Cyclophosphamide, vincristine and prednisolone
Rituximab, etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin
Disease free survival
Diffuse large B-cell lymphoma
Deoxyribonucleic acid
Event-free survival
Flurodeoxyglucose
Flurodeoxyglucose Positron Emission Tomography
Fluorescence in situ hybridisation
Follicular lymphoma
Follicular lymphoma international prognostic index
Guideline Committee
Granulocyte-colony stimulating factor
Gene expression profiling
General practitioner
Grading of Recommendations, Assessment, Development and Evaluation
Graft versus host disease
Gray
Allogeneic transplantation
High dose chemotherapy
Human Immunodeficiency Virus
Haematological Malignancies Research Network
Hazard ratio
Healthcare resource group
Health related quality of life
Autologous transplantation
Incremental cost-effectiveness ratio
Immunohistochemistry
Immunohistochemistry - fluorescence in situ hybridisation
International Prognostic Index
Lactate dehydrogenase
Liver function test
Mucosal associated lymphoid tissue
Mitoxantrone, chlorambucil and prednisolone
Electronic Market Information Tool
Mantle cell lymphoma
Mantle cell lymphoma international prognostic index-biological
Marginal zone lymphoma
National Cancer Action Team
Non-Hodgkin's lymphomaActiv
National Health Service
Negative predictive value
Non-relapsed mortality
Office of National Statistics
Overall survival
Polymerase chain reaction
Positron Emission Tomography – Computed Tomogrpahy
Progression free survival
Population, Intervention, Comparison, Outcome
Primary mediastinal B-cell lymphoma
Positive predictive value
Probability sensitivity analysis
Peripheral T-cell lymphoma
Peripheral T-cell lymphoma not otherwise specified
Quality adjusted life year
Quality of life
Quality Assessment of Diagnostic Accuracy Studies 2
Rituximab plus Berlin–Frankfurt–Münster regimen
Rituximab, cyclophosphamide, doxorubicin, etoposide, vincristine and prednisolone
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone
Rituximab, cyclophosphamide, doxorubicin, vincristine, cytarabine and methotrexate
Randomised control trial
Rituximab, gemcitabine, dexamethasone and cisplatin
Rituximab, cyclophosphamide, vincristine, doxorubicin and dexamethasone, (methotrexate and cytarabine)
Rituximab plus Lymphome Malin B regimen
Ribonucleic acid
Allogeneic stem cell transplant
Autologous stem cell transplant
Surveillance, Epidemiology and End Results
Total body irradiation
Treatment related mortality
Urea and electrolytes
World Health Organisation
All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.
Your browsing activity is empty.
Activity recording is turned off.
See more...
